연구동향 분석
박사

Heterogeneity in etiology and prognosis of breast cancer by intrinsic subtypes : 유방암 아형에 따른 발생 및 예후인자의 이질성 연구

송난 2015년

논문상세정보
인용/피인용
' Heterogeneity in etiology and prognosis of breast cancer by intrinsic subtypes : 유방암 아형에 따른 발생 및 예후인자의 이질성 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • breast cancer
  • genome-wide association study
  • heterogeneity
  • intrinsic subtype
  • prognostic factor
  • risk factor
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
917 0

0.0%

' Heterogeneity in etiology and prognosis of breast cancer by intrinsic subtypes : 유방암 아형에 따른 발생 및 예후인자의 이질성 연구' 의 참고문헌

  • van Bogaert LJ. Breast cancer molecular subtypes as identified byimmunohistochemistry in South African black women. The breast journal. 2013Mar-Apr;19(2):210-1. PubMed PMID: 23294416.
  • Zhu P, Baek SH, Bourk EM, Ohgi KA, Garcia-Bassets I, Sanjo H, et al.Macrophage/cancer cell interactions mediate hormone resistance by a nuclearreceptor derepression pathway. Cell. 2006 Feb 10;124(3):615-29. PubMed PMID:16469706.
  • Zheng W, Long J, Gao YT, Li C, Zheng Y, Xiang YB, et al. Genome-wideassociation study identifies a new breast cancer susceptibility locus at 6q25.1.Nature genetics. 2009 Mar;41(3):324-8. PubMed PMID: 19219042. Pubmed CentralPMCID: 2754845.
  • Zhao J, Liu H, Wang M, Gu L, Guo X, Gu F, et al. Characteristics andprognosis for molecular breast cancer subtypes in Chinese women. Journal ofsurgical oncology. 2009 Aug 1;100(2):89-94. PubMed PMID: 19544363.145
  • Zaha DC, Lazar E, Lazureanu C. Clinicopathologic features and five yearssurvival analysis in molecular subtypes of breast cancer. Romanian journal ofmorphology and embryology = Revue roumaine de morphologie et embryologie.2010;51(1):85-9. PubMed PMID: 20191125.
  • Yu K, Lee CH, Tan PH, Tan P. Conservation of breast cancer molecularsubtypes and transcriptional patterns of tumor progression across distinct ethnicpopulations. Clinical cancer research : an official journal of the AmericanAssociation for Cancer Research. 2004 Aug 15;10(16):5508-17. PubMed PMID:15328190.
  • Yerushalmi R, Gelmon KA, Leung S, Gao D, Cheang M, Pollak M, et al.Insulin-like growth factor receptor (IGF-1R) in breast cancer subtypes. Breastcancer research and treatment. 2012 Feb;132(1):131-42. PubMed PMID: 21574055.
  • Yang Z, Shen J, Cao Z, Wang B. Association between a novelpolymorphism (rs2046210) of the 6q25.1 locus and breast cancer risk. Breast cancerresearch and treatment. 2013 May;139(1):267-75. PubMed PMID: 23609471.
  • Yang XR, Sherman ME, Rimm DL, Lissowska J, Brinton LA, Peplonska B,et al. Differences in risk factors for breast cancer molecular subtypes in apopulation-based study. Cancer epidemiology, biomarkers & prevention : apublication of the American Association for Cancer Research, cosponsored by theAmerican Society of Preventive Oncology. 2007 Mar;16(3):439-43. PubMed PMID:17372238.
  • Yang XR, Chang-Claude J, Goode EL, Couch FJ, Nevanlinna H, Milne RL,et al. Associations of breast cancer risk factors with tumor subtypes: a pooledanalysis from the Breast Cancer Association Consortium studies. Journal of theNational Cancer Institute. 2011 Feb 2;103(3):250-63. PubMed PMID: 21191117.Pubmed Central PMCID: 3107570.
  • Yanagawa M, Ikemot K, Kawauchi S, Furuya T, Yamamoto S, Oka M, et al.Luminal A and luminal B (HER2 negative) subtypes of breast cancer consist of amixture of tumors with different genotype. BMC research notes. 2012;5:376.PubMed PMID: 22830453. Pubmed Central PMCID: 3413599.
  • Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. The NewEngland journal of medicine. 2006 Jan 19;354(3):270-82. PubMed PMID: 16421368.
  • Xue C, Wang X, Peng R, Shi Y, Qin T, Liu D, et al. Distribution,clinicopathologic features and survival of breast cancer subtypes in Southern China.Cancer science. 2012 Sep;103(9):1679-87. PubMed PMID: 22625227. PubmedCentral PMCID: 3466418.
  • Xu X, Gammon MD, Wetmur JG, Bradshaw PT, Teitelbaum SL, Neugut AI,et al. B-vitamin intake, one-carbon metabolism, and survival in a population-basedstudy of women with breast cancer. Cancer epidemiology, biomarkers & prevention :a publication of the American Association for Cancer Research, cosponsored by theAmerican Society of Preventive Oncology. 2008 Aug;17(8):2109-16. PubMedPMID: 18708404. Pubmed Central PMCID: 2673236.
  • Xing P, Li J, Jin F. A case-control study of reproductive factors associatedwith subtypes of breast cancer in Northeast China. Medical oncology. 2010Sep;27(3):926-31. PubMed PMID: 19771534.
  • Wiechmann L, Sampson M, Stempel M, Jacks LM, Patil SM, King T, et al.Presenting features of breast cancer differ by molecular subtype. Annals of surgicaloncology. 2009 Oct;16(10):2705-10. PubMed PMID: 19593632.
  • Whiteman MK, Hillis SD, Curtis KM, McDonald JA, Wingo PA,Marchbanks PA. Reproductive history and mortality after breast cancer diagnosis.Obstetrics and gynecology. 2004 Jul;104(1):146-54. PubMed PMID: 15229014.
  • Welsh ML, Buist DS, Aiello Bowles EJ, Anderson ML, Elmore JG, Li CI.Population-based estimates of the relation between breast cancer risk, tumor subtype,and family history. Breast cancer research and treatment. 2009 Apr;114(3):549-58.PubMed PMID: 18437558. Pubmed Central PMCID: 2692346.
  • Wang Y, Yin Q, Yu Q, Zhang J, Liu Z, Wang S, et al. A retrospective studyof breast cancer subtypes: the risk of relapse and the relations with treatments.Breast cancer research and treatment. 2011 Nov;130(2):489-98. PubMed PMID:21837481.
  • Wang DY, Rubens RD, Allen DS, Millis RR, Bulbrook RD, Chaudary MA,et al. Influence of reproductive history on age at diagnosis of breast cancer andprognosis. International journal of cancer Journal international du cancer. 1985 Oct15;36(4):427-32. PubMed PMID: 4044053.
  • Voduc KD, Cheang MC, Tyldesley S, Gelmon K, Nielsen TO, Kennecke H.Breast cancer subtypes and the risk of local and regional relapse. Journal of clinicaloncology : official journal of the American Society of Clinical Oncology. 2010 Apr1;28(10):1684-91. PubMed PMID: 20194857.
  • Visvader JE. Cells of origin in cancer. Nature. 2011 Jan 20;469(7330):314-22. PubMed PMID: 21248838.
  • Vilatoba M, Eckstein C, Bilbao G, Frennete L, Eckhoff DE, Contreras JL.17beta-estradiol differentially activates mitogen-activated protein-kinases andimproves survival following reperfusion injury of reduced-size liver in mice.Transplantation proceedings. 2005 Jan-Feb;37(1):399-403. PubMed PMID:15808658.
  • Verma S, Bal A, Joshi K, Arora S, Singh G. Immunohistochemicalcharacterization of molecular subtypes of invasive breast cancer: a study from NorthIndia. APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.2012 Dec;120(12):1008-19. PubMed PMID: 23030684.
  • Vallejos CS, Gomez HL, Cruz WR, Pinto JA, Dyer RR, Velarde R, et al.Breast cancer classification according to immunohistochemistry markers: subtypesand association with clinicopathologic variables in a peruvian hospital database.Clinical breast cancer. 2010 Aug 1;10(4):294-300. PubMed PMID: 20705562.155
  • Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, et al.Genome-wide association study identifies five new breast cancer susceptibility loci.Nature genetics. 2010 Jun;42(6):504-7. PubMed PMID: 20453838. Pubmed CentralPMCID: 3632836.
  • Trivers KF, Lund MJ, Porter PL, Liff JM, Flagg EW, Coates RJ, et al. Theepidemiology of triple-negative breast cancer, including race. Cancer causes &control : CCC. 2009 Sep;20(7):1071-82. PubMed PMID: 19343511.
  • Trivers KF, Gammon MD, Abrahamson PE, Lund MJ, Flagg EW, KaufmanJS, et al. Association between reproductive factors and breast cancer survival in143younger women. Breast cancer research and treatment. 2007 May;103(1):93-102.PubMed PMID: 17004111.
  • Thomas G, Jacobs KB, Kraft P, Yeager M, Wacholder S, Cox DG, et al. Amultistage genome-wide association study in breast cancer identifies two new risk133alleles at 1p11.2 and 14q24.1 (RAD51L1). Nature genetics. 2009 May;41(5):579-84.PubMed PMID: 19330030. Pubmed Central PMCID: 2928646.
  • Tamimi RM, Colditz GA, Hazra A, Baer HJ, Hankinson SE, Rosner B, et al.Traditional breast cancer risk factors in relation to molecular subtypes of breastcancer. Breast cancer research and treatment. 2012 Jan;131(1):159-67. PubMedPMID: 21830014. Pubmed Central PMCID: 3237947.
  • Sueta A, Ito H, Islam T, Hosono S, Watanabe M, Hirose K, et al.Differential impact of body mass index and its change on the risk of breast cancer bymolecular subtype: A case-control study in Japanese women. SpringerPlus. 2012Dec;1(1):39. PubMed PMID: 23350064. Pubmed Central PMCID: 3550694.
  • Su Y, Zheng Y, Zheng W, Gu K, Chen Z, Li G, et al. Distinct distributionand prognostic significance of molecular subtypes of breast cancer in Chinese151women: a population-based cohort study. BMC cancer. 2011;11:292. PubMedPMID: 21749714. Pubmed Central PMCID: 3157458.
  • Stingl J, Caldas C. Molecular heterogeneity of breast carcinomas and thecancer stem cell hypothesis. Nature reviews Cancer. 2007 Oct;7(10):791-9. PubMedPMID: 17851544.169
  • Stevens KN, Vachon CM, Lee AM, Slager S, Lesnick T, Olswold C, et al.Common breast cancer susceptibility loci are associated with triple-negative breastcancer. Cancer research. 2011 Oct 1;71(19):6240-9. PubMed PMID: 21844186.Pubmed Central PMCID: 3327299.
  • Stevens KN, Vachon CM, Couch FJ. Genetic susceptibility to triplenegativebreast cancer. Cancer research. 2013 Apr 1;73(7):2025-30. PubMed PMID:23536562. Pubmed Central PMCID: 3654815.
  • Stevens KN, Fredericksen Z, Vachon CM, Wang X, Margolin S, LindblomA, et al. 19p13.1 is a triple-negative-specific breast cancer susceptibility locus.Cancer research. 2012 Apr 1;72(7):1795-803. PubMed PMID: 22331459. PubmedCentral PMCID: 3319792.
  • Stark A, Schultz D, Kapke A, Nadkarni P, Burke M, Linden M, et al.Obesity and risk of the less commonly diagnosed subtypes of breast cancer.European journal of surgical oncology : the journal of the European Society ofSurgical Oncology and the British Association of Surgical Oncology. 2009Sep;35(9):928-35. PubMed PMID: 19121564.
  • Stacey SN, Manolescu A, Sulem P, Thorlacius S, Gudjonsson SA, JonssonGF, et al. Common variants on chromosome 5p12 confer susceptibility to estrogen135receptor-positive breast cancer. Nature genetics. 2008 Jun;40(6):703-6. PubMedPMID: 18438407.
  • Stacey SN, Manolescu A, Sulem P, Rafnar T, Gudmundsson J, GudjonssonSA, et al. Common variants on chromosomes 2q35 and 16q12 confer susceptibilityto estrogen receptor-positive breast cancer. Nature genetics. 2007 Jul;39(7):865-9.PubMed PMID: 17529974.134
  • Spitale A, Mazzola P, Soldini D, Mazzucchelli L, Bordoni A. Breast cancerclassification according to immunohistochemical markers: clinicopathologic featuresand short-term survival analysis in a population-based study from the South of164Switzerland. Annals of oncology : official journal of the European Society forMedical Oncology / ESMO. 2009 Apr;20(4):628-35. PubMed PMID: 19074747.
  • Sparano JA, Wang M, Zhao F, Stearns V, Martino S, Ligibel JA, et al.Obesity at diagnosis is associated with inferior outcomes in hormone receptorpositiveoperable breast cancer. Cancer. 2012 Dec 1;118(23):5937-46. PubMedPMID: 22926690. Pubmed Central PMCID: 3586227.
  • Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A, et al.Repeated observation of breast tumor subtypes in independent gene expression datasets. Proceedings of the National Academy of Sciences of the United States ofAmerica. 2003 Jul 8;100(14):8418-23. PubMed PMID: 12829800. Pubmed CentralPMCID: 166244.
  • Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, et al. Geneexpression patterns of breast carcinomas distinguish tumor subclasses with clinicalimplications. Proceedings of the National Academy of Sciences of the United Statesof America. 2001 Sep 11;98(19):10869-74. PubMed PMID: 11553815. PubmedCentral PMCID: 58566.
  • Smigielski EM, Sirotkin K, Ward M, Sherry ST. dbSNP: a database ofsingle nucleotide polymorphisms. Nucleic acids research. 2000 Jan 1;28(1):352-5.PubMed PMID: 10592272. Pubmed Central PMCID: 102496.
  • Smid M, Wang Y, Zhang Y, Sieuwerts AM, Yu J, Klijn JG, et al. Subtypesof breast cancer show preferential site of relapse. Cancer research. 2008 May1;68(9):3108-14. PubMed PMID: 18451135.
  • Siddiq A, Couch FJ, Chen GK, Lindstrom S, Eccles D, Millikan RC, et al. Ameta-analysis of genome-wide association studies of breast cancer identifies twonovel susceptibility loci at 6q14 and 20q11. Human molecular genetics. 2012 Dec15;21(24):5373-84. PubMed PMID: 22976474. Pubmed Central PMCID: 3510753.
  • Shu XO, Long J, Lu W, Li C, Chen WY, Delahanty R, et al. Novel geneticmarkers of breast cancer survival identified by a genome-wide association study.Cancer research. 2012 Mar 1;72(5):1182-9. PubMed PMID: 22232737. PubmedCentral PMCID: 3294129.
  • Shrubsole MJ, Shu XO, Ruan ZX, Cai Q, Cai H, Niu Q, et al. MTHFRgenotypes and breast cancer survival after surgery and chemotherapy: a report fromthe Shanghai Breast Cancer Study. Breast cancer research and treatment. 2005May;91(1):73-9. PubMed PMID: 15868433.167
  • Shibuta K, Ueo H, Furusawa H, Komaki K, Rai Y, Sagara Y, et al. Therelevance of intrinsic subtype to clinicopathological features and prognosis in 4,266Japanese women with breast cancer. Breast cancer. 2011 Oct;18(4):292-8. PubMedPMID: 20571962.152
  • Schwartzbaum JA, Hulka BS, Fowler WC, Jr., Kaufman DG, Hoberman D.The influence of exogenous estrogen use on survival after diagnosis of endometrialcancer. American journal of epidemiology. 1987 Nov;126(5):851-60. PubMedPMID: 3661533.
  • Schouten LJ, Hupperets PS, Jager JJ, Volovics L, Wils JA, Verbeek AL, etal. Prognostic significance of etiological risk factors in early breast cancer. Breastcancer research and treatment. 1997 May;43(3):217-23. PubMed PMID: 9150901.
  • Schmidt MK, Tollenaar RA, de Kemp SR, Broeks A, Cornelisse CJ, SmitVT, et al. Breast cancer survival and tumor characteristics in premenopausal womencarrying the CHEK2*1100delC germline mutation. Journal of clinical oncology :official journal of the American Society of Clinical Oncology. 2007 Jan 1;25(1):64-
  • Schedin P. Pregnancy-associated breast cancer and metastasis. Naturereviews Cancer. 2006 Apr;6(4):281-91. PubMed PMID: 16557280.
  • Sapkota Y, Yasui Y, Lai R, Sridharan M, Robson PJ, Cass CE, et al.Identification of a breast cancer susceptibility locus at 4q31.22 using a genome-wideassociation study paradigm. PloS one. 2013;8(5):e62550. PubMed PMID: 23717390.Pubmed Central PMCID: 3661567.
  • Sanpaolo P, Barbieri V, Genovesi D. Prognostic value of breast cancersubtypes on breast cancer specific survival, distant metastases and local relapse ratesin conservatively managed early stage breast cancer: a retrospective clinical study.European journal of surgical oncology : the journal of the European Society ofSurgical Oncology and the British Association of Surgical Oncology. 2011Oct;37(10):876-82. PubMed PMID: 21824742.
  • Salhia B, Tapia C, Ishak EA, Gaber S, Berghuis B, Hussain KH, et al.Molecular subtype analysis determines the association of advanced breast cancer in156Egypt with favorable biology. BMC women's health. 2011;11:44. PubMed PMID:21961708. Pubmed Central PMCID: 3204283.
  • Rosenberg L, Thalib L, Adami HO, Hall P. Childbirth and breast cancerprognosis. International journal of cancer Journal international du cancer. 2004 Sep20;111(5):772-6. PubMed PMID: 15252849.141
  • Rose DP, Vona-Davis L. Interaction between menopausal status and obesityin affecting breast cancer risk. Maturitas. 2010 May;66(1):33-8. PubMed PMID:20181446.
  • Roberts MR, Hong CC, Edge SB, Yao S, Bshara W, Higgins MJ, et al.Case-only analyses of the associations between polymorphisms in the metastasismodifyinggenes BRMS1 and SIPA1 and breast tumor characteristics, lymph nodemetastasis, and survival. Breast cancer research and treatment. 2013 Jun;139(3):873-
  • Rich JD, Cannon CP, Murphy SA, Qin J, Giugliano RP, Braunwald E. Prioraspirin use and outcomes in acute coronary syndromes. Journal of the AmericanCollege of Cardiology. 2010 Oct 19;56(17):1376-85. PubMed PMID: 20946994.
  • Riaz M, Berns EM, Sieuwerts AM, Ruigrok-Ritstier K, de Weerd V,Groenewoud A, et al. Correlation of breast cancer susceptibility loci with patientcharacteristics, metastasis-free survival, and mRNA expression of the nearest genes.Breast cancer research and treatment. 2012 Jun;133(3):843-51. PubMed PMID:21748294.
  • Reeves GK, Patterson J, Vessey MP, Yeates D, Jones L. Hormonal andother factors in relation to survival among breast cancer patients. Internationaljournal of cancer Journal international du cancer. 2000 May 20;89(3):293-9.PubMed PMID: 10861507.
  • Redondo CM, Gago-Dominguez M, Ponte SM, Castelo ME, Jiang X, GarciaAA, et al. Breast feeding, parity and breast cancer subtypes in a Spanish cohort.PloS one. 2012;7(7):e40543. PubMed PMID: 22792365. Pubmed Central PMCID:3394701.
  • Ray G, Husain SA. Role of lipids, lipoproteins and vitamins in women withbreast cancer. Clinical biochemistry. 2001 Feb;34(1):71-6. PubMed PMID:11239519.
  • Ray A, Cleary MP. Obesity and breast cancer: a clinical biochemistryperspective. Clinical biochemistry. 2012 Feb;45(3):189-97. PubMed PMID:22178111.
  • Rafiq S, Tapper W, Collins A, Khan S, Politopoulos I, Gerty S, et al.Identification of inherited genetic variations influencing prognosis in early-onsetbreast cancer. Cancer research. 2013 Mar 15;73(6):1883-91. PubMed PMID:23319801. Pubmed Central PMCID: 3601979.
  • Purrington KS, Slettedahl S, Bolla MK, Michailidou K, Czene K,Nevanlinna H, et al. Genetic variation in mitotic regulatory pathway genes isassociated with breast tumor grade. Human molecular genetics. 2014 Nov15;23(22):6034-46. PubMed PMID: 24927736. Pubmed Central PMCID: 4204763.
  • Purrington KS, Slager S, Eccles D, Yannoukakos D, Fasching PA, Miron P,et al. Genome-wide association study identifies 25 known breast cancersusceptibility loci as risk factors for triple-negative breast cancer. Carcinogenesis.2014 May;35(5):1012-9. PubMed PMID: 24325915. Pubmed Central PMCID:4004200.
  • PubMed PMID: 6571917.94. Phillips KA, Milne RL, Friedlander ML, Jenkins MA, McCredie MR, GilesGG, et al. Prognosis of premenopausal breast cancer and childbirth prior todiagnosis. Journal of clinical oncology : official journal of the American Society ofClinical Oncology. 2004 Feb 15;22(4):699-705. PubMed PMID: 14966094.
  • PubMed PMID: 24107615. Pubmed Central PMCID: 3864715.232. Moon HG, Han W, Noh DY. Underweight and breast cancer recurrence anddeath: a report from the Korean Breast Cancer Society. Journal of clinical oncology :166official journal of the American Society of Clinical Oncology. 2009 Dec10;27(35):5899-905. PubMed PMID: 19805676.
  • PubMed PMID: 23771732. Pubmed Central PMCID: 3819326.119. Fu F, Wang C, Chen LM, Huang M, Huang HG. The influence of functionalpolymorphisms in matrix metalloproteinase 9 on survival of breast cancer patients ina Chinese population. DNA and cell biology. 2013 May;32(5):274-82. PubMedPMID: 23570558.
  • PubMed PMID: 21364029. Pubmed Central PMCID: 3064558.74. Long J, Cai Q, Shu XO, Qu S, Li C, Zheng Y, et al. Identification of afunctional genetic variant at 16q12.1 for breast cancer risk: results from the AsiaBreast Cancer Consortium. PLoS genetics. 2010 Jun;6(6):e1001002. PubMed PMID:20585626. Pubmed Central PMCID: 2891809.
  • PubMed PMID: 21263130.57. Sehrawat B, Sridharan M, Ghosh S, Robson P, Cass CE, Mackey JR, et al.Potential novel candidate polymorphisms identified in genome-wide associationstudy for breast cancer susceptibility. Human genetics. 2011 Oct;130(4):529-37.PubMed PMID: 21424380. Pubmed Central PMCID: 3178778.
  • PubMed PMID: 19800812.186. Woditschka S, Habel LA, Udaltsova N, Friedman GD, Sieh W. Lipophilicstatin use and risk of breast cancer subtypes. Cancer epidemiology, biomarkers &prevention : a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology. 2010Oct;19(10):2479-87. PubMed PMID: 20729289. Pubmed Central PMCID: 2952055.159
  • PubMed PMID: 17132695.
  • PubMed PMID: 10963602.
  • Pruim RJ, Welch RP, Sanna S, Teslovich TM, Chines PS, Gliedt TP, et al.LocusZoom: regional visualization of genome-wide association scan results.Bioinformatics. 2010 Sep 15;26(18):2336-7. PubMed PMID: 20634204. PubmedCentral PMCID: 2935401.
  • Polyak K. Heterogeneity in breast cancer. The Journal of clinicalinvestigation. 2011 Oct;121(10):3786-8. PubMed PMID: 21965334. PubmedCentral PMCID: 3195489.
  • Pierobon M, Frankenfeld CL. Obesity as a risk factor for triple-negativebreast cancers: a systematic review and meta-analysis. Breast cancer research andtreatment. 2013 Jan;137(1):307-14. PubMed PMID: 23179600.
  • Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Reproductive andhormonal risk factors for postmenopausal luminal, HER-2-overexpressing, andtriple-negative breast cancer. Cancer. 2008 Oct 1;113(7):1521-6. PubMed PMID:18726992. Pubmed Central PMCID: 2587413.
  • Phipps AI, Malone KE, Porter PL, Daling JR, Li CI. Body size and risk ofluminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausalwomen. Cancer epidemiology, biomarkers & prevention : a publication of theAmerican Association for Cancer Research, cosponsored by the American Societyof Preventive Oncology. 2008 Aug;17(8):2078-86. PubMed PMID: 18664548.Pubmed Central PMCID: 2561180.
  • Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Wactawski-Wende J,Kuller LH, et al. Reproductive history and oral contraceptive use in relation to riskof triple-negative breast cancer. Journal of the National Cancer Institute. 2011 Mar16;103(6):470-7. PubMed PMID: 21346227. Pubmed Central PMCID: 3057984.
  • Phipps AI, Chlebowski RT, Prentice R, McTiernan A, Stefanick ML,Wactawski-Wende J, et al. Body size, physical activity, and risk of triple-negativeand estrogen receptor-positive breast cancer. Cancer epidemiology, biomarkers &prevention : a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology. 2011 Mar;20(3):454-
  • Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, etal. Reproductive history and risk of three breast cancer subtypes defined by threebiomarkers. Cancer causes & control : CCC. 2011 Mar;22(3):399-405. PubMedPMID: 21184265. Pubmed Central PMCID: 3042513.
  • Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, etal. Family history of breast cancer in first-degree relatives and triple-negative breastcancer risk. Breast cancer research and treatment. 2011 Apr;126(3):671-8. PubMedPMID: 20814817. Pubmed Central PMCID: 3059326.132
  • Phipps AI, Buist DS, Malone KE, Barlow WE, Porter PL, Kerlikowske K, etal. Breast density, body mass index, and risk of tumor marker-defined subtypes ofbreast cancer. Annals of epidemiology. 2012 May;22(5):340-8. PubMed PMID:22366170. Pubmed Central PMCID: 3338877.
  • Phillips KA, Milne RL, West DW, Goodwin PJ, Giles GG, Chang ET, et al.Prediagnosis reproductive factors and all-cause mortality for women with breastcancer in the breast cancer family registry. Cancer epidemiology, biomarkers &prevention : a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology. 2009Jun;18(6):1792-7. PubMed PMID: 19505912. Pubmed Central PMCID: 2746957.
  • Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, et al.Molecular portraits of human breast tumours. Nature. 2000 Aug 17;406(6797):747-
  • Parise CA, Bauer KR, Caggiano V. Variation in breast cancer subtypes withage and race/ethnicity. Critical reviews in oncology/hematology. 2010 Oct;76(1):44-
  • Papatestas AE, Mulvihill M, Josi C, Ioannovich J, Lesnick G, Aufses AH, Jr.Parity and prognosis in breast cancer. Cancer. 1980 Jan 1;45(1):191-4. PubMedPMID: 7351001.
  • Ovsyannikova IG, Kennedy RB, O'Byrne M, Jacobson RM, Pankratz VS,Poland GA. Genome-wide association study of antibody response to smallpoxvaccine. Vaccine. 2012 Jun 13;30(28):4182-9. PubMed PMID: 22542470. PubmedCentral PMCID: 3367131.
  • Orgeas CC, Hall P, Rosenberg LU, Czene K. The influence of menstrualrisk factors on tumor characteristics and survival in postmenopausal breast cancer.Breast cancer research : BCR. 2008;10(6):R107. PubMed PMID: 19087323.Pubmed Central PMCID: 2656904.
  • Onitilo AA, Engel JM, Greenlee RT, Mukesh BN. Breast cancer subtypesbased on ER/PR and Her2 expression: comparison of clinicopathologic features andsurvival. Clinical medicine & research. 2009 Jun;7(1-2):4-13. PubMed PMID:19574486. Pubmed Central PMCID: 2705275.
  • Olson SH, Zauber AG, Tang J, Harlap S. Relation of time since last birthand parity to survival of young women with breast cancer. Epidemiology. 1998Nov;9(6):669-71. PubMed PMID: 9799180.
  • O'Brien KM, Cole SR, Engel LS, Bensen JT, Poole C, Herring AH, et al.Breast cancer subtypes and previously established genetic risk factors: a bayesianapproach. Cancer epidemiology, biomarkers & prevention : a publication of theAmerican Association for Cancer Research, cosponsored by the American Societyof Preventive Oncology. 2014 Jan;23(1):84-97. PubMed PMID: 24177593. PubmedCentral PMCID: 3947131.
  • Nissen-Meyer R. "Prophylactic" Ovariectomy and Ovarian Irradiation inBreast Cancer. Acta - Unio Internationalis Contra Cancrum. 1964;20:527-30.PubMed PMID: 14151979.
  • Niraula S, Ocana A, Ennis M, Goodwin PJ. Body size and breast cancerprognosis in relation to hormone receptor and menopausal status: a meta-analysis.Breast cancer research and treatment. 2012 Jul;134(2):769-81. PubMed PMID:22562122.
  • Newcombe RG. Two-sided confidence intervals for the single proportion:comparison of seven methods. Statistics in medicine. 1998 Apr 30;17(8):857-72.PubMed PMID: 9595616.
  • Naushad SM, Prayaga A, Digumarti RR, Gottumukkala SR, Kutala VK.Bcl-2/adenovirus E1B 19 kDa-interacting protein 3 (BNIP3) expression isepigenetically regulated by one-carbon metabolism in invasive duct cell carcinomaof breast. Molecular and cellular biochemistry. 2012 Feb;361(1-2):189-95. PubMedPMID: 21987236.
  • National Statistical Office (NSO).
  • Muendlein A, Lang AH, Geller-Rhomberg S, Winder T, Gasser K, Drexel H,et al. Association of a common genetic variant of the IGF-1 gene with event-freesurvival in patients with HER2-positive breast cancer. Journal of cancer researchand clinical oncology. 2013 Mar;139(3):491-8. PubMed PMID: 23180020.147
  • Morrison DH, Rahardja D, King E, Peng Y, Sarode VR. Tumour biomarkerexpression relative to age and molecular subtypes of invasive breast cancer. Britishjournal of cancer. 2012 Jul 10;107(2):382-7. PubMed PMID: 22713661. PubmedCentral PMCID: 3394967.
  • Mohle-Boetani JC, Grosser S, Whittemore AS, Malec M, Kampert JB,Paffenbarger RS, Jr. Body size, reproductive factors, and breast cancer survival.Preventive medicine. 1988 Sep;17(5):634-42. PubMed PMID: 3237661.
  • Millikan RC, Newman B, Tse CK, Moorman PG, Conway K, Dressler LG,et al. Epidemiology of basal-like breast cancer. Breast cancer research and treatment.2008 May;109(1):123-39. PubMed PMID: 17578664. Pubmed Central PMCID:2443103.160
  • Mersin H, Gulben K, Berberoglu U, Yazi M, Acun G, Kinas V, et al.Prognostic factors affecting postmastectomy locoregional recurrence in patients withearly breast cancer: are intrinsic subtypes effective? World journal of surgery. 2011Oct;35(10):2196-202. PubMed PMID: 21853356.
  • McPherson K, Steel CM, Dixon JM. ABC of breast diseases. Breast cancerepidemiology,risk factors, and genetics. BMJ. 2000 Sep 9;321(7261):624-8.PubMed PMID: 10977847. Pubmed Central PMCID: 1118507.
  • Mazouni C, Rimareix F, Mathieu MC, Uzan C, Bourgier C, Andre F, et al.Outcome in breast molecular subtypes according to nodal status and surgicalprocedures. American journal of surgery. 2013 Jun;205(6):662-7. PubMed PMID:23312273.
  • Matakidou A, El Galta R, Rudd MF, Webb EL, Bridle H, Eisen T, et al.Prognostic significance of folate metabolism polymorphisms for lung cancer. Britishjournal of cancer. 2007 Jul 16;97(2):247-52. PubMed PMID: 17533396. PubmedCentral PMCID: 2360297.
  • Martinez ME, Cruz GI, Brewster AM, Bondy ML, Thompson PA. What canwe learn about disease etiology from case-case analyses? Lessons from breast cancer.Cancer epidemiology, biomarkers & prevention : a publication of the AmericanAssociation for Cancer Research, cosponsored by the American Society ofPreventive Oncology. 2010 Nov;19(11):2710-4. PubMed PMID: 20870734.
  • Martin DN, Boersma BJ, Howe TM, Goodman JE, Mechanic LE, ChanockSJ, et al. Association of MTHFR gene polymorphisms with breast cancer survival.BMC cancer. 2006;6:257. PubMed PMID: 17069650. Pubmed Central PMCID:1634868.
  • Marnett LJ, Tuttle MA. Comparison of the mutagenicities ofmalondialdehyde and the side products formed during its chemical synthesis. Cancerresearch. 1980 Feb;40(2):276-82. PubMed PMID: 6985838.
  • Maiti B, Kundranda MN, Spiro TP, Daw HA. The association of metabolicsyndrome with triple-negative breast cancer. Breast cancer research and treatment.2010 Jun;121(2):479-83. PubMed PMID: 19851862.
  • Ma H, Wang Y, Sullivan-Halley J, Weiss L, Marchbanks PA, Spirtas R, etal. Use of four biomarkers to evaluate the risk of breast cancer subtypes in thewomen's contraceptive and reproductive experiences study. Cancer research. 2010Jan 15;70(2):575-87. PubMed PMID: 20068186. Pubmed Central PMCID: 2807992.
  • Lyons TR, Schedin PJ, Borges VF. Pregnancy and breast cancer: when theycollide. Journal of mammary gland biology and neoplasia. 2009 Jun;14(2):87-98.PubMed PMID: 19381788. Pubmed Central PMCID: 2693784.162
  • Lund MJ, Butler EN, Hair BY, Ward KC, Andrews JH, Oprea-Ilies G, et al.Age/race differences in HER2 testing and in incidence rates for breast cancer triplesubtypes: a population-based study and first report. Cancer. 2010 Jun1;116(11):2549-59. PubMed PMID: 20336785.
  • Low SK, Takahashi A, Ashikawa K, Inazawa J, Miki Y, Kubo M, et al.Genome-wide association study of breast cancer in the Japanese population. PloSone. 2013;8(10):e76463. PubMed PMID: 24143190. Pubmed Central PMCID:3797071.
  • Long J, Zhang B, Signorello LB, Cai Q, Deming-Halverson S, ShrubsoleMJ, et al. Evaluating genome-wide association study-identified breast cancer riskvariants in African-American women. PloS one. 2013;8(4):e58350. PubMed PMID:23593120. Pubmed Central PMCID: 3620157.140
  • Long J, Cai Q, Sung H, Shi J, Zhang B, Choi JY, et al. Genome-wideassociation study in east Asians identifies novel susceptibility loci for breast cancer.PLoS genetics. 2012;8(2):e1002532. PubMed PMID: 22383897. Pubmed CentralPMCID: 3285588.
  • Liu LP, Bai J, Wei Y, Qi XD, Si TC, Li W, et al. [Clinicopathologic featuresand immunohistochemistry of the basal-like subtype of invasive breast carcinoma].Zhonghua bing li xue za zhi Chinese journal of pathology. 2013 Feb;42(2):101-5.PubMed PMID: 23710916.
  • Lindstrom LS, Hall P, Hartman M, Wiklund F, Gronberg H, Czene K.Familial concordance in cancer survival: a Swedish population-based study. TheLancet Oncology. 2007 Nov;8(11):1001-6. PubMed PMID: 17921068.
  • Lin CH, Liau JY, Lu YS, Huang CS, Lee WC, Kuo KT, et al. Molecularsubtypes of breast cancer emerging in young women in Taiwan: evidence for morethan just westernization as a reason for the disease in Asia. Cancer epidemiology,biomarkers & prevention : a publication of the American Association for CancerResearch, cosponsored by the American Society of Preventive Oncology. 2009Jun;18(6):1807-14. PubMed PMID: 19505913.
  • Li LQ, Min LS, Jiang Q, Ping JL, Li J, Dai LC. Progranulin expression inbreast cancer with different intrinsic subtypes. Pathology, research and practice.2012 Apr 15;208(4):210-6. PubMed PMID: 22397762.
  • Li J, Humphreys K, Heikkinen T, Aittomaki K, Blomqvist C, Pharoah PD,et al. A combined analysis of genome-wide association studies in breast cancer.Breast cancer research and treatment. 2011 Apr;126(3):717-27. PubMed PMID:20872241.
  • Li CI, Beaber EF, Tang MT, Porter PL, Daling JR, Malone KE.Reproductive factors and risk of estrogen receptor positive, triple-negative, andHER2-neu overexpressing breast cancer among women 20-44 years of age. Breastcancer research and treatment. 2013 Jan;137(2):579-87. PubMed PMID: 23224237.Pubmed Central PMCID: 3547981.
  • Lees AW, Jenkins HJ, May CL, Cherian G, Lam EW, Hanson J. Riskfactors and 10-year breast cancer survival in northern Alberta. Breast cancerresearch and treatment. 1989 Mar;13(2):143-51. PubMed PMID: 2730961.
  • Lee Y, Lee SA, Choi JY, Song M, Sung H, Jeon S, et al. Prognosis of breastcancer is associated with one-carbon metabolism related nutrients among Koreanwomen. Nutrition journal. 2012;11:59. PubMed PMID: 22929014. Pubmed CentralPMCID: 3478215.
  • Lee JS, Oh M, Korean Breast Cancer S, Korean Breast Cancer S.Reproductive factors and subtypes of breast cancer defined by estrogen receptor,progesterone receptor, and human epidermal growth factor receptor 2: a registerbasedstudy from Korea. Clinical breast cancer. 2014 Dec;14(6):426-34. PubMedPMID: 25034438.
  • Lee E, Van Den Berg D, Hsu C, Ursin G, Koh WP, Yuan JM, et al. Geneticvariation in transforming growth factor beta 1 and mammographic density inSingapore Chinese women. Cancer research. 2013 Mar 15;73(6):1876-82. PubMedPMID: 23333936. Pubmed Central PMCID: 3740538.
  • Lane DM, Boatman KK, McConathy WJ. Serum lipids and apolipoproteinsin women with breast masses. Breast cancer research and treatment. 1995May;34(2):161-9. PubMed PMID: 7647333.
  • Kwan ML, Kushi LH, Weltzien E, Maring B, Kutner SE, Fulton RS, et al.Epidemiology of breast cancer subtypes in two prospective cohort studies of breastcancer survivors. Breast cancer research : BCR. 2009;11(3):R31. PubMed PMID:19463150. Pubmed Central PMCID: 2716499.
  • Kwan ML, John EM, Caan BJ, Lee VS, Bernstein L, Cheng I, et al. Obesityand mortality after breast cancer by race/ethnicity: The California Breast CancerSurvivorship Consortium. American journal of epidemiology. 2014 Jan 1;179(1):95-
  • Kurian AW. BRCA1 and BRCA2 mutations across race and ethnicity:distribution and clinical implications. Current opinion in obstetrics & gynecology.2010 Feb;22(1):72-8. PubMed PMID: 19841585.
  • Kurebayashi J, Moriya T, Ishida T, Hirakawa H, Kurosumi M, Akiyama F,et al. The prevalence of intrinsic subtypes and prognosis in breast cancer patients ofdifferent races. Breast. 2007 Dec;16 Suppl 2:S72-7. PubMed PMID: 17714947.
  • Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T,Melbye M. Time since childbirth and prognosis in primary breast cancer: populationbased study. Bmj. 1997 Oct 4;315(7112):851-5. PubMed PMID: 9353505. PubmedCentral PMCID: 2127579.
  • Kroman N, Wohlfahrt J, Andersen KW, Mouridsen HT, Westergaard T,Melbye M. Parity, age at first childbirth and the prognosis of primary breast cancer.British journal of cancer. 1998 Dec;78(11):1529-33. PubMed PMID: 9836489.Pubmed Central PMCID: 2063201.
  • Kroman N, Mouridsen HT. Prognostic influence of pregnancy before,around, and after diagnosis of breast cancer. Breast. 2003 Dec;12(6):516-21.PubMed PMID: 14659129.
  • Korzeniowski S, Dyba T. Reproductive history and prognosis in patientswith operable breast cancer. Cancer. 1994 Sep 1;74(5):1591-4. PubMed PMID:8062190.142
  • Korean Breast Cancer Society. 2006.
  • Korean Breast Cancer Society (KBCS). 2014.161
  • Kneubil MC, Brollo J, Botteri E, Curigliano G, Rotmensz N, Goldhirsch A,et al. Breast cancer subtype approximations and loco-regional recurrence afterimmediate breast reconstruction. European journal of surgical oncology : the journalof the European Society of Surgical Oncology and the British Association ofSurgical Oncology. 2013 Mar;39(3):260-5. PubMed PMID: 23313014.
  • Kiyotani K, Mushiroda T, Tsunoda T, Morizono T, Hosono N, Kubo M, etal. A genome-wide association study identifies locus at 10q22 associated withclinical outcomes of adjuvant tamoxifen therapy for breast cancer patients in146Japanese. Human molecular genetics. 2012 Apr 1;21(7):1665-72. PubMed PMID:22180457.
  • Kim HC, Lee JY, Sung H, Choi JY, Park SK, Lee KM, et al. A genomewideassociation study identifies a breast cancer risk variant in ERBB4 at 2q34:results from the Seoul Breast Cancer Study. Breast cancer research : BCR.2012;14(2):R56. PubMed PMID: 22452962. Pubmed Central PMCID: 3446390.
  • Kim EK, Noh WC, Han W, Noh DY. Prognostic significance of young age(<35 years) by subtype based on ER, PR, and HER2 status in breast cancer: anationwide registry-based study. World journal of surgery. 2011 Jun;35(6):1244-53.PubMed PMID: 21472372. Epub 2011/04/08. eng.
  • Kennecke H, Yerushalmi R, Woods R, Cheang MC, Voduc D, Speers CH,et al. Metastatic behavior of breast cancer subtypes. Journal of clinical oncology :official journal of the American Society of Clinical Oncology. 2010 Jul10;28(20):3271-7. PubMed PMID: 20498394.
  • Keegan TH, DeRouen MC, Press DJ, Kurian AW, Clarke CA. Occurrenceof breast cancer subtypes in adolescent and young adult women. Breast cancerresearch : BCR. 2012;14(2):R55. PubMed PMID: 22452927. Pubmed CentralPMCID: 3446389.
  • Kawai M, Malone KE, Tang MT, Li CI. Height, body mass index (BMI),BMI change, and the risk of estrogen receptor-positive, HER2-positive, and triplenegativebreast cancer among women ages 20 to 44 years. Cancer. 2014 May15;120(10):1548-56. PubMed PMID: 24500704. Pubmed Central PMCID: 4013221.138
  • Karolchik D, Barber GP, Casper J, Clawson H, Cline MS, Diekhans M, et al.The UCSC Genome Browser database: 2014 update. Nucleic acids research. 2014Jan;42(Database issue):D764-70. PubMed PMID: 24270787. Pubmed CentralPMCID: 3964947.
  • Kang HS, Lee SC, Park YS, Jeon YE, Lee JH, Jung SY, et al. Protein andlipid MALDI profiles classify breast cancers according to the intrinsic subtype.BMC cancer. 2011;11:465. PubMed PMID: 22029885. Pubmed Central PMCID:3218066.
  • Kadivar M, Mafi N, Joulaee A, Shamshiri A, Hosseini N. Breast cancermolecular subtypes and associations with clinicopathological characteristics inIranian women, 2002- 2011. Asian Pacific journal of cancer prevention : APJCP.2012;13(5):1881-6. PubMed PMID: 22901141.
  • Juret P, Couette JE, Mandard AM, Carre A, Delozier T, Brune D, et al. Ageat menarche as a prognostic factor in human breast cancer. European journal ofcancer. 1976 Sep;12(9):701-4. PubMed PMID: 971692.
  • Jung KW, Won YJ, Kong HJ, Oh CM, Seo HG, Lee JS. Cancer statistics inKorea: incidence, mortality, survival and prevalence in 2010. Cancer research andtreatment : official journal of Korean Cancer Association. 2013 Mar;45(1):1-14.PubMed PMID: 23613665. Pubmed Central PMCID: 3629358.
  • Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, deBakker PI. SNAP: a web-based tool for identification and annotation of proxy SNPsusing HapMap. Bioinformatics. 2008 Dec 15;24(24):2938-9. PubMed PMID:18974171. Pubmed Central PMCID: 2720775.
  • Jenkins EO, Deal AM, Anders CK, Prat A, Perou CM, Carey LA, et al.Age-specific changes in intrinsic breast cancer subtypes: a focus on older women.The oncologist. 2014 Oct;19(10):1076-83. PubMed PMID: 25142841. PubmedCentral PMCID: 4200998.129
  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancerstatistics. CA: a cancer journal for clinicians. 2011 Mar-Apr;61(2):69-90. PubMedPMID: 21296855.
  • Jang G, Lee SS, Ahn JH, Jung KH, Lee H, Gong G, et al. Clinical featuresand course of brain metastases in triple-negative breast cancer: comparison withhuman epidermal growth factor receptor 2-positive and other type at singleinstitution in Korea. Breast cancer research and treatment. 2011 Jul;128(1):171-7.PubMed PMID: 21519835.
  • Jacobs TW, Gown AM, Yaziji H, Barnes MJ, Schnitt SJ. Specificity ofHercepTest in determining HER-2/neu status of breast cancers using the UnitedStates Food and Drug Administration-approved scoring system. Journal of clinicaloncology : official journal of the American Society of Clinical Oncology. 1999Jul;17(7):1983-7. PubMed PMID: 10561248.149
  • Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, et al.Clinicopathological analyses of triple negative breast cancer using surveillance datafrom the Registration Committee of the Japanese Breast Cancer Society. Breastcancer. 2010 Apr;17(2):118-24. PubMed PMID: 19466512.
  • Ishitobi M, Miyoshi Y, Ando A, Hasegawa S, Egawa C, Tamaki Y, et al.Association of BRCA2 polymorphism at codon 784 (Met/Val) with breast cancerrisk and prognosis. Clinical cancer research : an official journal of the AmericanAssociation for Cancer Research. 2003 Apr;9(4):1376-80. PubMed PMID:12684407.148
  • Irvin WJ, Jr., Carey LA. What is triple-negative breast cancer? Europeanjournal of cancer. 2008 Dec;44(18):2799-805. PubMed PMID: 19008097.
  • Irigoyen MA, Garcia FV, Iturriagagoitia AC, Beroiz BI, Martinez MS,Grima FG. [Molecular subtypes of breast cancer: prognostic implications andclinical and immunohistochemical characteristics]. Anales del sistema sanitario deNavarra. 2011 May-Aug;34(2):219-33. PubMed PMID: 21904404. Subtiposmoleculares del cancer de mama: implicaciones pronosticas y caracteristicas clinicase inmunohistoquimicas.
  • Ihemelandu CU, Leffall LD, Jr., Dewitty RL, Naab TJ, Mezghebe HM,Makambi KH, et al. Molecular breast cancer subtypes in premenopausal andpostmenopausal African-American women: age-specific prevalence and survival.The Journal of surgical research. 2007 Nov;143(1):109-18. PubMed PMID:17950079.
  • Ihemelandu CU, Leffall LD, Jr., Dewitty RL, Naab TJ, Mezghebe HM,Makambi KH, et al. Molecular breast cancer subtypes in premenopausal African-American women, tumor biologic factors and clinical outcome. Annals of surgicaloncology. 2007 Oct;14(10):2994-3003. PubMed PMID: 17647064.
  • Huo D, Ikpatt F, Khramtsov A, Dangou JM, Nanda R, Dignam J, et al.Population differences in breast cancer: survey in indigenous African women revealsover-representation of triple-negative breast cancer. Journal of clinical oncology :official journal of the American Society of Clinical Oncology. 2009 Sep20;27(27):4515-21. PubMed PMID: 19704069. Pubmed Central PMCID: 2754904.
  • Hunter DJ, Kraft P, Jacobs KB, Cox DG, Yeager M, Hankinson SE, et al. Agenome-wide association study identifies alleles in FGFR2 associated with risk ofsporadic postmenopausal breast cancer. Nature genetics. 2007 Jul;39(7):870-4.PubMed PMID: 17529973. Pubmed Central PMCID: 3493132.
  • Huertas-Vazquez A, Plaisier CL, Geng R, Haas BE, Lee J, GreevenbroekMM, et al. A nonsynonymous SNP within PCDH15 is associated with lipid traits in168familial combined hyperlipidemia. Human genetics. 2010 Jan;127(1):83-9. PubMedPMID: 19816713. Pubmed Central PMCID: 2793376.
  • Hsieh SM, Look MP, Sieuwerts AM, Foekens JA, Hunter KW. Distinctinherited metastasis susceptibility exists for different breast cancer subtypes: aprognosis study. Breast cancer research : BCR. 2009;11(5):R75. PubMed PMID:19825179. Pubmed Central PMCID: 2790856.
  • Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, etal. SEER Cancer Statistics Review, 1975-2006, National Cancer Institute. Bethesda,MD, http://seer.cancer.gov/csr/1975_2006/, based on November 2008 SEER datasubmission, posted to the SEER web site 2009.
  • Holst F, Stahl PR, Ruiz C, Hellwinkel O, Jehan Z, Wendland M, et al.Estrogen receptor alpha (ESR1) gene amplification is frequent in breast cancer.Nature genetics. 2007 May;39(5):655-60. PubMed PMID: 17417639.
  • Hines LM, Risendal B, Byers T, Mengshol S, Lowery J, Singh M. Ethnicdisparities in breast tumor phenotypic subtypes in Hispanic and non-Hispanic whitewomen. Journal of women's health. 2011 Oct;20(10):1543-50. PubMed PMID:21721934. Pubmed Central PMCID: 3186448.158
  • Hindorff L, MacArthur J, Junkins H, Hall P, Klemm A, Manolio T. ACatalog of Published Genome-Wide Association Studies. Available from:www.genome.gov/gwastudies.
  • Henderson IC, Patek AJ. The relationship between prognostic and predictivefactors in the management of breast cancer. Breast cancer research and treatment.1998;52(1-3):261-88. PubMed PMID: 10066087.
  • Hattangadi-Gluth JA, Wo JY, Nguyen PL, Abi Raad RF, Sreedhara M,Niemierko A, et al. Basal subtype of invasive breast cancer is associated with ahigher risk of true recurrence after conventional breast-conserving therapy.International journal of radiation oncology, biology, physics. 2012 Mar1;82(3):1185-91. PubMed PMID: 21601377. Pubmed Central PMCID: 3161144.
  • Haque R, Ahmed SA, Inzhakova G, Shi J, Avila C, Polikoff J, et al. Impactof breast cancer subtypes and treatment on survival: an analysis spanning twodecades. Cancer epidemiology, biomarkers & prevention : a publication of theAmerican Association for Cancer Research, cosponsored by the American Society157of Preventive Oncology. 2012 Oct;21(10):1848-55. PubMed PMID: 22989461.Pubmed Central PMCID: 3467337.
  • Han W, Woo JH, Yu JH, Lee MJ, Moon HG, Kang D, et al. Commongenetic variants associated with breast cancer in Korean women and differentialsusceptibility according to intrinsic subtype. Cancer epidemiology, biomarkers &prevention : a publication of the American Association for Cancer Research,cosponsored by the American Society of Preventive Oncology. 2011May;20(5):793-8. PubMed PMID: 21415360.
  • Hall C, Krishnamurthy S, Lodhi A, Mosalpuria K, Kuerer HM, Meric-Bernstam F, et al. Disseminated tumor cells in biologic subtypes of stage I-III breastcancer patients. Annals of surgical oncology. 2010 Dec;17(12):3252-8. PubMedPMID: 20559739.
  • Haiman CA, Chen GK, Vachon CM, Canzian F, Dunning A, Millikan RC,et al. A common variant at the TERT-CLPTM1L locus is associated with estrogenreceptor-negative breast cancer. Nature genetics. 2011 Dec;43(12):1210-4. PubMedPMID: 22037553. Pubmed Central PMCID: 3279120.
  • HUGO Gene Nomenclature Committee (HGNC).
  • Gupta PB, Proia D, Cingoz O, Weremowicz J, Naber SP, Weinberg RA, etal. Systemic stromal effects of estrogen promote the growth of estrogen receptornegativecancers. Cancer research. 2007 Mar 1;67(5):2062-71. PubMed PMID:17332335.
  • Guinee VF, Olsson H, Moller T, Hess KR, Taylor SH, Fahey T, et al. Effectof pregnancy on prognosis for young women with breast cancer. Lancet. 1994 Jun25;343(8913):1587-9. PubMed PMID: 7911917.
  • Gudmundsdottir ET, Barkardottir RB, Arason A, Gunnarsson H,Amundadottir LT, Agnarsson BA, et al. The risk allele of SNP rs3803662 and themRNA level of its closest genes TOX3 and LOC643714 predict adverse outcomefor breast cancer patients. BMC cancer. 2012;12:621. PubMed PMID: 23270421.Pubmed Central PMCID: 3553017.
  • Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, et al.The impact of obesity on the short-term and long-term outcomes after percutaneous165coronary intervention: the obesity paradox? Journal of the American College ofCardiology. 2002 Feb 20;39(4):578-84. PubMed PMID: 11849854.
  • Gollapudi L, Oblinger MM. Stable transfection of PC12 cells with estrogenreceptor (ERalpha): protective effects of estrogen on cell survival after serumdeprivation. Journal of neuroscience research. 1999 Apr 1;56(1):99-108. PubMedPMID: 10213481.
  • Goldhirsch A, Wood WC, Coates AS, Gelber RD, Thurlimann B, Senn HJ,et al. Strategies for subtypes--dealing with the diversity of breast cancer: highlightsof the St. Gallen International Expert Consensus on the Primary Therapy of EarlyBreast Cancer 2011. Annals of oncology : official journal of the European Societyfor Medical Oncology / ESMO. 2011 Aug;22(8):1736-47. PubMed PMID:21709140. Pubmed Central PMCID: 3144634.127
  • Gold B, Kirchhoff T, Stefanov S, Lautenberger J, Viale A, Garber J, et al.Genome-wide association study provides evidence for a breast cancer risk locus at6q22.33. Proceedings of the National Academy of Sciences of the United States ofAmerica. 2008 Mar 18;105(11):4340-5. PubMed PMID: 18326623. Pubmed CentralPMCID: 2393811.136
  • Ghoussaini M, Fletcher O, Michailidou K, Turnbull C, Schmidt MK, DicksE, et al. Genome-wide association analysis identifies three new breast cancer137susceptibility loci. Nature genetics. 2012 Mar;44(3):312-8. PubMed PMID:22267197. Pubmed Central PMCID: 3653403.
  • Gaudet MM, Press MF, Haile RW, Lynch CF, Glaser SL, Schildkraut J, etal. Risk factors by molecular subtypes of breast cancer across a population-based131study of women 56 years or younger. Breast cancer research and treatment. 2011Nov;130(2):587-97. PubMed PMID: 21667121. Pubmed Central PMCID: 3721192.
  • Garcia-Closas M, Hall P, Nevanlinna H, Pooley K, Morrison J, RichessonDA, et al. Heterogeneity of breast cancer associations with five susceptibility loci byclinical and pathological characteristics. PLoS genetics. 2008 Apr;4(4):e1000054.PubMed PMID: 18437204. Pubmed Central PMCID: 2291027.
  • Garcia-Closas M, Couch FJ, Lindstrom S, Michailidou K, Schmidt MK,Brook MN, et al. Genome-wide association studies identify four ER negativespecificbreast cancer risk loci. Nature genetics. 2013 Apr;45(4):392-8, 8e1-2.PubMed PMID: 23535733. Pubmed Central PMCID: 3771695.
  • Garcia Fernandez A, Gimenez N, Fraile M, Gonzalez S, Chabrera C, TorrasM, et al. Survival and clinicopathological characteristics of breast cancer patientaccording to different tumour subtypes as determined by hormone receptor and Her2immunohistochemistry. a single institution survey spanning 1998 to 2010. Breast.2012 Jun;21(3):366-73. PubMed PMID: 22487206.
  • Fletcher O, Johnson N, Orr N, Hosking FJ, Gibson LJ, Walker K, et al.Novel breast cancer susceptibility locus at 9q31.2: results of a genome-wideassociation study. Journal of the National Cancer Institute. 2011 Mar 2;103(5):425-
  • Figueroa JD, Garcia-Closas M, Humphreys M, Platte R, Hopper JL,Southey MC, et al. Associations of common variants at 1p11.2 and 14q24.1(RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findingsfrom the Breast Cancer Association Consortium. Human molecular genetics. 2011Dec 1;20(23):4693-706. PubMed PMID: 21852249. Pubmed Central PMCID:3209823.139
  • Ferguson NL, Bell J, Heidel R, Lee S, Vanmeter S, Duncan L, et al.Prognostic value of breast cancer subtypes, Ki-67 proliferation index, age, and153pathologic tumor characteristics on breast cancer survival in Caucasian women. Thebreast journal. 2013 Jan-Feb;19(1):22-30. PubMed PMID: 23240985.
  • Fasching PA, Pharoah PD, Cox A, Nevanlinna H, Bojesen SE, Karn T, et al.The role of genetic breast cancer susceptibility variants as prognostic factors.126Human molecular genetics. 2012 Sep 1;21(17):3926-39. PubMed PMID: 22532573.Pubmed Central PMCID: 3412377.
  • Fanous AH, Kendler KS. Genetic heterogeneity, modifier genes, andquantitative phenotypes in psychiatric illness: searching for a framework. Molecularpsychiatry. 2005 Jan;10(1):6-13. PubMed PMID: 15618952.
  • Eroglu A, Karabiyik A, Akar N. The association of protease activatedreceptor 1 gene -506 I/D polymorphism with disease-free survival in breast cancerpatients. Annals of surgical oncology. 2012 Apr;19(4):1365-9. PubMed PMID:21822552.
  • Elgazzar S, Zembutsu H, Takahashi A, Kubo M, Aki F, Hirata K, et al. Agenome-wide association study identifies a genetic variant in the SIAH2 locusassociated with hormonal receptor-positive breast cancer in Japanese. Journal ofhuman genetics. 2012 Dec;57(12):766-71. PubMed PMID: 22951594.
  • El-Hawary AK, Abbas AS, Elsayed AA, Zalata KR. Molecular subtypes ofbreast carcinoma in Egyptian women: clinicopathological features. Pathology,research and practice. 2012 Jul 15;208(7):382-6. PubMed PMID: 22641056.
  • El Fatemi H, Chahbouni S, Jayi S, Moumna K, Melhouf MA, Bannani A, etal. Luminal B tumors are the most frequent molecular subtype in breast cancer ofNorth African women: an immunohistochemical profile study from Morocco.Diagnostic pathology. 2012;7:170. PubMed PMID: 23216981. Pubmed CentralPMCID: 3538531.
  • Edge SB, Compton CC. The American Joint Committee on Cancer: the 7thedition of the AJCC cancer staging manual and the future of TNM. Annals ofsurgical oncology. 2010 Jun;17(6):1471-4. PubMed PMID: 20180029.
  • Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, BallingerDG, et al. Genome-wide association study identifies novel breast cancersusceptibility loci. Nature. 2007 Jun 28;447(7148):1087-93. PubMed PMID:17529967. Pubmed Central PMCID: 2714974.
  • Dumenil G, Rubini M, Dubois G, Baserga R, Fellous M, Pellegrini S.Identification of signalling components in tyrosine kinase cascades usingphosphopeptide affinity chromatography. Biochemical and biophysical researchcommunications. 1997 May 29;234(3):748-53. PubMed PMID: 9175787.
  • Dong DD, Yie SM, Li K, Li F, Xu Y, Xu G, et al. Importance of HLA-Gexpression and tumor infiltrating lymphocytes in molecular subtypes of breastcancer. Human immunology. 2012 Oct;73(10):998-1004. PubMed PMID: 22841927.
  • Devi CR, Tang TS, Corbex M. Incidence and risk factors for breast cancersubtypes in three distinct South-East Asian ethnic groups: Chinese, Malay and130natives of Sarawak, Malaysia. International journal of cancer Journal internationaldu cancer. 2012 Dec 15;131(12):2869-77. PubMed PMID: 22407763.
  • Daniel M, Peek GW, Tollefsbol TO. Regulation of the human catalyticsubunit of telomerase (hTERT). Gene. 2012 May 1;498(2):135-46. PubMed PMID:22381618. Pubmed Central PMCID: 3312932.
  • Daling JR, Malone KE, Doody DR, Anderson BO, Porter PL. The relationof reproductive factors to mortality from breast cancer. Cancer epidemiology,biomarkers & prevention : a publication of the American Association for CancerResearch, cosponsored by the American Society of Preventive Oncology. 2002Mar;11(3):235-41. PubMed PMID: 11895871.
  • Dahabreh IJ, Kent DM. Index event bias as an explanation for the paradoxesof recurrence risk research. Jama. 2011 Feb 23;305(8):822-3. PubMed PMID:21343582. Pubmed Central PMCID: 4115579.
  • Cutrupi S, Reineri S, Panetto A, Grosso E, Caizzi L, Ricci L, et al.Targeting of the adaptor protein Tab2 as a novel approach to revert tamoxifenresistance in breast cancer cells. Oncogene. 2012 Oct 4;31(40):4353-61. PubMedPMID: 22249258.
  • Creighton CJ, Hilger AM, Murthy S, Rae JM, Chinnaiyan AM, El-Ashry D.Activation of mitogen-activated protein kinase in estrogen receptor alpha-positivebreast cancer cells in vitro induces an in vivo molecular phenotype of estrogenreceptor alpha-negative human breast tumors. Cancer research. 2006 Apr1;66(7):3903-11. PubMed PMID: 16585219.
  • Crabb SJ, Cheang MC, Leung S, Immonen T, Nielsen TO, Huntsman DD, etal. Basal breast cancer molecular subtype predicts for lower incidence of axillarylymph node metastases in primary breast cancer. Clinical breast cancer. 2008Jun;8(3):249-56. PubMed PMID: 18650155.
  • Couch FJ, Wang X, McGuffog L, Lee A, Olswold C, Kuchenbaecker KB, etal. Genome-wide association study in BRCA1 mutation carriers identifies novel lociassociated with breast and ovarian cancer risk. PLoS genetics. 2013;9(3):e1003212.PubMed PMID: 23544013. Pubmed Central PMCID: 3609646.
  • Conroy SM, Maskarinec G, Wilkens LR, White KK, Henderson BE,Kolonel LN. Obesity and breast cancer survival in ethnically diversepostmenopausal women: the Multiethnic Cohort Study. Breast cancer research andtreatment. 2011 Sep;129(2):565-74. PubMed PMID: 21499688. Pubmed CentralPMCID: 3164157.
  • Clarke CA, Keegan TH, Yang J, Press DJ, Kurian AW, Patel AH, et al.Age-specific incidence of breast cancer subtypes: understanding the black-whitecrossover. Journal of the National Cancer Institute. 2012 Jul 18;104(14):1094-101.PubMed PMID: 22773826. Pubmed Central PMCID: 3640371.
  • Clark GM. Prognostic and Predictive Factors for Breast Cancer. Breastcancer. 1995 Oct 31;2(2):79-89. PubMed PMID: 11091537.
  • Chuthapisith S, Permsapaya W, Warnnissorn M, Akewanlop C,Sirivatanauksorn V, Prasarttong Osoth P. Breast cancer subtypes identified by theER, PR and HER-2 status in Thai women. Asian Pacific journal of cancerprevention : APJCP. 2012;13(2):459-62. PubMed PMID: 22524806.
  • Chung S, Low SK, Zembutsu H, Takahashi A, Kubo M, Sasa M, et al. Agenome-wide association study of chemotherapy-induced alopecia in breast cancerpatients. Breast cancer research : BCR. 2013;15(5):R81. PubMed PMID: 24025145.Pubmed Central PMCID: 3978764.
  • Chuang E, Paul C, Flam A, McCarville K, Forst M, Shin S, et al. Breastcancer subtypes in Asian-Americans differ according to Asian ethnic group. Journalof immigrant and minority health / Center for Minority Public Health. 2012Oct;14(5):754-8. PubMed PMID: 22286607. Pubmed Central PMCID: 4051206.
  • Choi HK, Nguyen US, Niu J, Danaei G, Zhang Y. Selection bias inrheumatic disease research. Nature reviews Rheumatology. 2014 Jul;10(7):403-12.PubMed PMID: 24686510. Pubmed Central PMCID: 4260806.
  • Chen FY, Ou HY, Wang SM, Wu YH, Yan GJ, Tang LL. Associationsbetween body mass index and molecular subtypes as well as other clinicalcharacteristics of breast cancer in Chinese women. Therapeutics and clinical riskmanagement. 2013;9:131-7. PubMed PMID: 23576872. Pubmed Central PMCID:3617914.
  • Chen F, Chen GK, Stram DO, Millikan RC, Ambrosone CB, John EM, et al.A genome-wide association study of breast cancer in women of African ancestry.Human genetics. 2013 Jan;132(1):39-48. PubMed PMID: 22923054. PubmedCentral PMCID: 3749077.
  • Cheang MC, Voduc D, Bajdik C, Leung S, McKinney S, Chia SK, et al.Basal-like breast cancer defined by five biomarkers has superior prognostic valuethan triple-negative phenotype. Clinical cancer research : an official journal of theAmerican Association for Cancer Research. 2008 Mar 1;14(5):1368-76. PubMedPMID: 18316557.
  • Cheang MC, Chia SK, Voduc D, Gao D, Leung S, Snider J, et al. Ki67index, HER2 status, and prognosis of patients with luminal B breast cancer. Journalof the National Cancer Institute. 2009 May 20;101(10):736-50. PubMed PMID:19436038. Pubmed Central PMCID: 2684553.128
  • Caudle AS, Yu TK, Tucker SL, Bedrosian I, Litton JK, Gonzalez-AnguloAM, et al. Local-regional control according to surrogate markers of breast cancersubtypes and response to neoadjuvant chemotherapy in breast cancer patientsundergoing breast conserving therapy. Breast cancer research : BCR.2012;14(3):R83. PubMed PMID: 22621334. Pubmed Central PMCID: 3446346.
  • Castaneda CA, Andres E, Barcena C, Gomez HL, Cortes-Funes H, CiruelosE. Behaviour of breast cancer molecular subtypes through tumour progression.Clinical & translational oncology : official publication of the Federation of Spanish154Oncology Societies and of the National Cancer Institute of Mexico. 2012Jun;14(6):481-5. PubMed PMID: 22634538. Epub 2012/05/29. eng.
  • Carey LA, Perou CM, Livasy CA, Dressler LG, Cowan D, Conway K, et al.Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study.Jama. 2006 Jun 7;295(21):2492-502. PubMed PMID: 16757721.
  • Cai Q, Zhang B, Sung H, Low SK, Kweon SS, Lu W, et al. Genome-wideassociation analysis in East Asians identifies breast cancer susceptibility loci at1q32.1, 5q14.3 and 15q26.1. Nature genetics. 2014 Aug;46(8):886-90. PubMedPMID: 25038754. Pubmed Central PMCID: 4127632.
  • Cai Q, Long J, Lu W, Qu S, Wen W, Kang D, et al. Genome-wideassociation study identifies breast cancer risk variant at 10q21.2: results from theAsia Breast Cancer Consortium. Human molecular genetics. 2011 Dec15;20(24):4991-9. PubMed PMID: 21908515. Pubmed Central PMCID: 3221542.
  • Butt S, Borgquist S, Garne JP, Landberg G, Tengrup I, Olsson A, et al.Parity in relation to survival following breast cancer. European journal of surgicaloncology : the journal of the European Society of Surgical Oncology and the BritishAssociation of Surgical Oncology. 2009 Jul;35(7):702-8. PubMed PMID: 18490128.
  • Brosens JJ, Lam EW, Parker MG. Inflammation and sex steroid receptors: amotif for change. Cell. 2006 Feb 10;124(3):466-8. PubMed PMID: 16469693.
  • Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al.Low penetrance breast cancer susceptibility loci are associated with specific breasttumor subtypes: findings from the Breast Cancer Association Consortium. Humanmolecular genetics. 2011 Aug 15;20(16):3289-303. PubMed PMID: 21596841.Pubmed Central PMCID: PMC3140824. Epub 2011/05/21. eng.
  • Broeks A, Schmidt MK, Sherman ME, Couch FJ, Hopper JL, Dite GS, et al.Low penetrance breast cancer susceptibility loci are associated with specific breasttumor subtypes: findings from the Breast Cancer Association Consortium. Humanmolecular genetics. 2011 Aug 15;20(16):3289-303. PubMed PMID: 21596841.Pubmed Central PMCID: 3140824.
  • Boyapati SM, Shu XO, Ruan ZX, Cai Q, Smith JR, Wen W, et al.Polymorphisms in ER-alpha gene interact with estrogen receptor status in breastcancer survival. Clinical cancer research : an official journal of the AmericanAssociation for Cancer Research. 2005 Feb 1;11(3):1093-8. PubMed PMID:15709176.
  • Bonnier P, Romain S, Dilhuydy JM, Bonichon F, Julien JP, Charpin C, et al.Influence of pregnancy on the outcome of breast cancer: a case-control study.Societe Francaise de Senologie et de Pathologie Mammaire Study Group.International journal of cancer Journal international du cancer. 1997 Sep4;72(5):720-7. PubMed PMID: 9311584.
  • Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, etal. Multiple independent variants at the TERT locus are associated with telomere163length and risks of breast and ovarian cancer. Nature genetics. 2013 Apr;45(4):371-84, 84e1-2. PubMed PMID: 23535731. Pubmed Central PMCID: 3670748.
  • Blows FM, Driver KE, Schmidt MK, Broeks A, van Leeuwen FE,Wesseling J, et al. Subtyping of breast cancer by immunohistochemistry toinvestigate a relationship between subtype and short and long term survival: acollaborative analysis of data for 10,159 cases from 12 studies. PLoS medicine.2010 May;7(5):e1000279. PubMed PMID: 20520800. Pubmed Central PMCID:2876119.
  • Bladstrom A, Anderson H, Olsson H. Worse survival in breast canceramong women with recent childbirth: results from a Swedish population-based144register study. Clinical breast cancer. 2003 Oct;4(4):280-5. PubMed PMID:14651773.
  • Black MM, Hankey BF, Barclay TH. Parity as a prognostic factor in youngbreast cancer patients. Journal of the National Cancer Institute. 1983 Jan;70(1):27-
  • Benson JR. Role of transforming growth factor beta in breast carcinogenesis.The Lancet Oncology. 2004 Apr;5(4):229-39. PubMed PMID: 15050954.
  • Bennis S, Abbass F, Akasbi Y, Znati K, Joutei KA, El Mesbahi O, et al.Prevalence of molecular subtypes and prognosis of invasive breast cancer in northeastof Morocco: retrospective study. BMC research notes. 2012;5:436. PubMedPMID: 22889054. Pubmed Central PMCID: 3532150.
  • Benjamin EJ, Dupuis J, Larson MG, Lunetta KL, Booth SL, GovindarajuDR, et al. Genome-wide association with select biomarker traits in the FraminghamHeart Study. BMC medical genetics. 2007;8 Suppl 1:S11. PubMed PMID:17903293. Pubmed Central PMCID: 1995615.
  • Ben Abdelkrim S, Trabelsi A, Missaoui N, Beizig N, Bdioui A, Anjorin A,et al. Distribution of molecular breast cancer subtypes among Tunisian women andcorrelation with histopathological parameters: a study of 194 patients. Pathology,research and practice. 2010 Nov 15;206(11):772-5. PubMed PMID: 20850937.
  • Barnett GC, Shah M, Redman K, Easton DF, Ponder BA, Pharoah PD. Riskfactors for the incidence of breast cancer: do they affect survival from the disease?Journal of clinical oncology : official journal of the American Society of ClinicalOncology. 2008 Jul 10;26(20):3310-6. PubMed PMID: 18612147.
  • Baglin T. Unraveling the thrombophilia paradox: from hypercoagulability tothe prothrombotic state. Journal of thrombosis and haemostasis : JTH. 2010Feb;8(2):228-33. PubMed PMID: 19943876.
  • Azzato EM, Tyrer J, Fasching PA, Beckmann MW, Ekici AB, Schulz-Wendtland R, et al. Association between a germline OCA2 polymorphism atchromosome 15q13.1 and estrogen receptor-negative breast cancer survival. Journalof the National Cancer Institute. 2010 May 5;102(9):650-62. PubMed PMID:20308648. Pubmed Central PMCID: 2864289.
  • Azzato EM, Pharoah PD, Harrington P, Easton DF, Greenberg D, CaporasoNE, et al. A genome-wide association study of prognosis in breast cancer. Cancerepidemiology, biomarkers & prevention : a publication of the American Associationfor Cancer Research, cosponsored by the American Society of Preventive Oncology.2010 Apr;19(4):1140-3. PubMed PMID: 20332263. Pubmed Central PMCID:2852476.
  • Aulchenko YS, Struchalin MV, van Duijn CM. ProbABEL package forgenome-wide association analysis of imputed data. BMC bioinformatics.2010;11:134. PubMed PMID: 20233392. Pubmed Central PMCID: 2846909.
  • Aulchenko YS, Ripke S, Isaacs A, van Duijn CM. GenABEL: an R libraryfor genome-wide association analysis. Bioinformatics. 2007 May 15;23(10):1294-6.PubMed PMID: 17384015.150
  • Antoniou AC, Wang X, Fredericksen ZS, McGuffog L, Tarrell R,Sinilnikova OM, et al. A locus on 19p13 modifies risk of breast cancer in BRCA1mutation carriers and is associated with hormone receptor-negative breast cancer inthe general population. Nature genetics. 2010 Oct;42(10):885-92. PubMed PMID:20852631. Pubmed Central PMCID: 3130795.
  • Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME. How manyetiological subtypes of breast cancer: two, three, four, or more? Journal of theNational Cancer Institute. 2014 Aug;106(8). PubMed PMID: 25118203. PubmedCentral PMCID: 4148600.
  • Anderson WF, Chen BE, Brinton LA, Devesa SS. Qualitative ageinteractions (or effect modification) suggest different cancer pathways for earlyonsetand late-onset breast cancers. Cancer causes & control : CCC. 2007Dec;18(10):1187-98. PubMed PMID: 17823850.
  • Althuis MD, Fergenbaum JH, Garcia-Closas M, Brinton LA, Madigan MP,Sherman ME. Etiology of hormone receptor-defined breast cancer: a systematicreview of the literature. Cancer epidemiology, biomarkers & prevention : apublication of the American Association for Cancer Research, cosponsored by theAmerican Society of Preventive Oncology. 2004 Oct;13(10):1558-68. PubMedPMID: 15466970.
  • Alsaker MD, Opdahl S, Romundstad PR, Vatten LJ. Association of timesince last birth, age at first birth and parity with breast cancer survival among parouswomen: a register-based study from Norway. International journal of cancer Journalinternational du cancer. 2013 Jan 1;132(1):174-81. PubMed PMID: 22511284.
  • Ahmed S, Thomas G, Ghoussaini M, Healey CS, Humphreys MK, Platte R,et al. Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.Nature genetics. 2009 May;41(5):585-90. PubMed PMID: 19330027. PubmedCentral PMCID: 2748125.
  • Adebamowo CA, Famooto A, Ogundiran TO, Aniagwu T, Nkwodimmah C,Akang EE. Immunohistochemical and molecular subtypes of breast cancer inNigeria. Breast cancer research and treatment. 2008 Jul;110(1):183-8. PubMedPMID: 17674190.